510(k) device
NovoSorb BTM
Polynovo Biomaterials Pty, Ltd. · Absorbable Synthetic Wound Dressing (QSZ, Unclassified) · First FDA decision Aug 11, 2017, newest Jun 20, 2025BurnsChronic wounds and ulcers
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
4
Naming "NovoSorb BTM"
MAUDE reports
90
Brand "NovoSorb BTM", since 2015
PubMed studies
36
Mentioning "NovoSorb BTM"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing NovoSorb BTM
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- NovoSorb BTM510(k)
K251567 · Decided Jun 20, 2025 · 29 days after receipt
Device type: Absorbable Synthetic Wound Dressing (QSZ) · General & Plastic Surgery
K172140 · Decided Aug 11, 2017 · 25 days after receipt
Device type: Absorbable Synthetic Wound Dressing (QSZ) · General & Plastic Surgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "NovoSorb BTM", any status and sponsor, newest update first.
The Metis FoundationAcademic, hospital or other
NCT06503406 · 24 participants (planned) · Start Jan 8, 2026 · Primary completion Dec 2027
Device: SupraSDRM®; NovoSorb® BTM · For: Surgical Wound; Burns; Trauma Injury
Sites: Fort Sam Houston, Texas
- Assessment of Safety and Effectiveness of NovoSorb® BTM in Severe BurnsPivotal-lookingActive, not recruiting
PolyNovo Biomaterials Pty Ltd.Not on our public-company list
NCT04090424 · 150 participants (planned) · Start Sep 21, 2021 · Primary completion May 30, 2026
Device: NovoSorb BTM · For: Burns
Sites: Phoenix, Arizona; Los Angeles, California; Sacramento, California · 26 sites in all
Joseph M. Still Research Foundation, Inc.Academic, hospital or other
NCT05477225 · 10 participants (planned) · Start Oct 1, 2022 · Primary completion Jul 30, 2024
Device: NovoSorb® BTM; Human Cadaveric Allograft · For: Hidradenitis Suppurativa
Sites: Augusta, Georgia
1 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "NovoSorb BTM", and for the whole product code for context.
This brand
90 reports: 6 malfunction, 83 injury, 1 death
Whole product code QSZ
86 reports: 7 malfunction, 79 injury, 0 death
Newest reports for this brand
- Novosorb BTMInjury
3007886187-2026-00018 · Received Oct 25, 2026
Device type: Absorbable Synthetic Wound Dressing (QSZ)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Bacterial Infection; Purulent Discharge; Hematoma; Medical device site infection
- NovoSorb BTMInjury
PolyNovo Biomaterials Pty Ltd.
3007886187-2026-00017 · Received Oct 25, 2026
Device type: Absorbable Synthetic Wound Dressing (QSZ)
Device problem as coded: Improper or Incorrect Procedure or Method
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- Novosorb BTMInjury
3007886187-2026-00016 · Received Oct 19, 2026 · Event dated Sep 22, 2026
Device type: Absorbable Synthetic Wound Dressing (QSZ)
Device problem as coded: Device Dislodged or Dislocated
Patient problem as coded: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "NovoSorb BTM"[tiab]. The summary above synthesizes these.
- Novosorb® BTM- history, production and application in challenging wounds.
Rajaram R, Zhang M, Premaratne G, et al. · Front Bioeng Biotechnol · 2024Review
- Novosorb Biodegradable Temporizing Matrix for Reconstruction of Complex Upper-Extremity Wounds.
Jou C, Chepla KJ · J Hand Surg Glob Online · 2024
- Secondary Healing Over NovoSorb BTM in the Management of Complex Nasal Defects.
McMahon ME, Browne R, Ibrahim S · Plast Reconstr Surg Glob Open · 2025
- The Use of NovoSorb BTM for Trauma Reconstruction: Illustrative Cases and a Proposed Decision-making Tool.
Hendrickson SA, Flod S, Misky AT, et al. · Plast Reconstr Surg Glob Open · 2024Case Reports
- Long-Term Histological Evaluation of a Novel Dermal Template in the Treatment of Pediatric Burns.
Gerster-Barzanji Z, Woodtli V, Klix M, et al. · Bioengineering (Basel) · 2024
- Approaches to Cheek Reconstruction following Mohs Surgery.
McAllister L, Thornton JF · Semin Plast Surg · 2024Review
- Clinical outcomes and resource utilisation in patients with major burns treated with NovoSorb® BTM.
Betar N, Maher D, Wheatley L, et al. · Burns · 2023
- Treatment of Necrotizing Fasciitis With NovoSorb Biodegradable Temporizing Matrix and RECELL Autologous Skin Cell Suspension: A Case Series.
Austin CL, Sodade OE, Harrison B, et al. · J Burn Care Res · 2024
- Reactive oxygen species-degradable polythioketal urethane foam dressings to promote porcine skin wound repair.
Patil P, Russo KA, McCune JT, et al. · Sci Transl Med · 2022Research Support, U.S. Gov't, Non-P.H.S., Research Support, N.I.H., Extramural
- The impossible abdomen in a complex patient: treatment with novosorb biodegradable temporizing matrix (BTM) for frozen abdomen with entero-atmospheric fistula.
Cerceo JR, Malkoc A, Mamoun L, et al. · J Surg Case Rep · 2024Case Reports
- NovoSorb Biodegradable Temporizing Matrix (PolyNovo) for Aesthetic Nasal Reconstruction: A Case Report of Rhinophyma Resurfacing.
Kyriazidis I, Demiri E, Lazaridou A, et al. · Cureus · 2025Case Reports
- Use of a synthetic biodegradable temporising matrix after necrotising fasciitis infection of the thigh.
ALNafisee D, Casey MC, Kelly JL · BMJ Case Rep · 2022Case Reports
Other devices of this type
Also filed under product code QSZ.
- RestrataAcera Surgical, Inc. · 510(k) 2026
- SiOxD® Wound MatrixSioxmed, LLC · 510(k) 2024
- HyalomatrixAnika Therapeutics, Inc. · 510(k) 2026
- LUOFUCON® Wound MatrixHuizhou Foryou Medical Devices Co., Ltd. · 510(k) 2026
- Redermo Wound MatrixBeijing Kreate Medical Co., Ltd. · 510(k) 2026
- NovoSorb® MTXPolynovo Biomaterials Pty, Ltd. · 510(k) 2025
- Restrata® MiniMatrixAcera Surgical, Inc. · 510(k) 2023
- NovoSorb MatrixPolynovo Biomaterials Pty, Ltd. · 510(k) 2022
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.